Clinical Trial Update: Non-Inferiority Trial Comparing Eurofarma's Experimental Product Saccharomyces Boulardii Versus Floratil® in the Prevention of Antibiotic-Associated Diarrhea [Phase 3]

View source ↗

Summary

Phase 3 non-inferiority trial comparing Eurofarma's Saccharomyces boulardii to Floratil for prevention of antibiotic-associated diarrhea has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibiotic-associated Diarrhea

Drugs mentioned

• Floratil (Saccharomyces boulardii)
• Saccharomyces boulardii (Eurofarma experimental product) (Saccharomyces boulardii)

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Antibiotics | Phase 3 | Status: WITHDRAWN